T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
JPMorgan Chase
JPM
|
+$1.7B |
| 2 |
Verizon
VZ
|
+$1.36B |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
| 4 |
US Bancorp
USB
|
+$1.29B |
| 5 |
Merck
MRK
|
+$1.23B |
Top Sells
| 1 |
Amazon
AMZN
|
+$5.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$4.57B |
| 3 |
Tesla
TSLA
|
+$3.67B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.43B |
Sector Composition
| 1 | Technology | 26.72% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.69% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Emergent Biosolutions
EBS
$418M
| $268K | ﹤0.01% |
22,717
-5,422
| -19% | -$64K |
|
2402
Editas Medicine
EDIT
$254M
| $268K | ﹤0.01% |
30,227
-4,381
| -13% | -$38.8K |
|
2403
Sanara MedTech
SMTI
$312M
| $268K | ﹤0.01% |
+5,900
| New | +$268K |
|
2404
Atara Biotherapeutics
ATRA
$80.8M
| $267K | ﹤0.01% |
3,253
-1,025
| -24% | -$84.1K |
|
2405
Clean Energy Fuels
CLNE
$570M
| $267K | ﹤0.01% |
51,353
+2,983
| +6% | +$15.5K |
|
|
TPIC
2406
DELISTED
TPI Composites
TPIC
| $267K | ﹤0.01% |
26,354
+1,952
| +8% | +$19.8K |
|
2407
Harrow
HROW
$1.59B
| $266K | ﹤0.01% |
18,000
-800
| -4% | -$11.8K |
|
|
KRON
2408
DELISTED
Kronos Bio
KRON
| $265K | ﹤0.01% |
163,592
-7,594
| -4% | -$12.3K |
|
2409
Rocket Lab Corporation Common Stock
RKLB
$22.8B
| $265K | ﹤0.01% |
70,356
+8,472
| +14% | +$31.9K |
|
2410
Simulations Plus
SLP
$311M
| $265K | ﹤0.01% |
7,236
-2,574
| -26% | -$94.3K |
|
2411
Universal Technical Institute
UTI
$1.5B
| $265K | ﹤0.01% |
39,415
+208
| +0.5% | +$1.4K |
|
|
ICPT
2412
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $265K | ﹤0.01% |
21,436
+466
| +2% | +$5.76K |
|
2413
Blink Charging
BLNK
$154M
| $264K | ﹤0.01% |
24,024
+6,176
| +35% | +$67.9K |
|
2414
Frontline
FRO
$5.27B
| $264K | ﹤0.01% |
21,731
+1,626
| +8% | +$19.8K |
|
2415
iShares National Muni Bond ETF
MUB
$39.9B
| – | – |
0
| – | -$688K |
|
2416
NWPX Infrastructure, Inc. Common Stock
NWPX
$502M
| $263K | ﹤0.01% |
7,796
-2,242
| -22% | -$75.6K |
|
|
CTO
2417
CTO Realty Growth
CTO
$539M
| $263K | ﹤0.01% |
14,382
+475
| +3% | +$8.69K |
|
|
CSII
2418
DELISTED
Cardiovascular Systems, Inc.
CSII
| $262K | ﹤0.01% |
19,241
+931
| +5% | +$12.7K |
|
2419
Funko
FNKO
$183M
| $261K | ﹤0.01% |
23,921
+692
| +3% | +$7.55K |
|
|
MODN
2420
DELISTED
MODEL N, INC.
MODN
| $261K | ﹤0.01% |
6,447
+383
| +6% | +$15.5K |
|
2421
Eventbrite
EB
$269M
| $260K | ﹤0.01% |
44,399
+1,733
| +4% | +$10.1K |
|
2422
MGP Ingredients
MGPI
$592M
| $260K | ﹤0.01% |
2,448
+188
| +8% | +$20K |
|
2423
Royal Bank of Canada
RY
$206B
| $260K | ﹤0.01% |
2,770
| – | – |
|
2424
Bank of N.T. Butterfield & Son
NTB
$1.86B
| $259K | ﹤0.01% |
8,683
+673
| +8% | +$20.1K |
|
|
HA
2425
DELISTED
Hawaiian Holdings, Inc.
HA
| $259K | ﹤0.01% |
25,254
+837
| +3% | +$8.58K |
|